The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Open accessAbstract
Metastasis, the dissemination and growth of neoplastic cells in an organ distinct from that in which they originated, is the most common cause of death in cancer patients. This is particularly true for pancreatic cancers, where most patients are diagnosed with metastatic disease and few show a sustained response to chemotherapy or radiation therapy. Whether the dismal prognosis of patients with pancreatic cancer compared to patients with other types of cancer is a result of late diagnosis or early dissemination of disease to distant organs is not known. Here we rely on data generated by sequencing the genomes of seven pancreatic cancer metastases to evaluate the clonal relationships among primary and metastatic cancers. We find that clonal populations that give rise to distant metastases are represented within the primary carcinoma, but these clones are genetically evolved from the original parental, non-metastatic clone. Thus, genetic heterogeneity of metastases reflects that within the primary carcinoma. A quantitative analysis of the timing of the genetic evolution of pancreatic cancer was performed, indicating at least a decade between the occurrence of the initiating mutation and the birth of the parental, non-metastatic founder cell. At least five more years are required for the acquisition of metastatic ability and patients die an average of two years thereafter. These data provide novel insights into the genetic features underlying pancreatic cancer progression and define a broad time window of opportunity for early detection to prevent deaths from metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“modeling studies performed on the mutational data have estimated that the timeline of multistep progression to invasive neoplasia in the pancreas likely spans multiple years and provides a theoretically wide window of opportunity for early detection27.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [27]
In the citing paper
“Pancreatic tumours are highly heterogeneous, both within and between individuals.66,67”
From Early detection of pancreatic cancer (2020) · cites this paper as [67]
In the citing paper
“It is now appreciated that most clinically relevant solid tumors are highly heterogeneous at the phenotypic, physiologic, and genomic levels (13–15) and that they continue to evolve over time.”
From Radiomics: Images Are More than Pictures, They Are Data (2016) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Self-citationCore Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationOlive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationMetastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2622 · Cited by 2,716
Isaacson, P. G., Doǧan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,913
Comparative lesion sequencing provides insights into tumor evolution
Jones, S., Chen, W.-D. D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Tibor Antal, A., Traulsen, A., Nowak, M. A., Siegel, C., Velculescu, V. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712345105 · Cited by 827
Self-citationAdvanced pancreatic carcinoma: current treatment and future challenges
Stathis, A., & Moore, M. J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.236 · Cited by 791
Signatures of mutation and selection in the cancer genome
Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707
Self-citationMaitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,006
DNA methylation intratumor heterogeneity in localized lung adenocarcinomas
Quek, K., Li, J., Estecio, M. R., Zhang, J., Fujimoto, J., Roarty, E. B., Little, L., Chow, C.-W. B., Song, X., Behrens, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15777 · Cited by 55
Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
Hu, D., Ansari, D., Pawłowski, K., Zhou, Q., Sasor, A., Welinder, C., Kristl, T., Bauden, M. P., Rezeli, M., Jiang, Y., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.23929 · Cited by 59
Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma
Lin, L., & Lin, D. (2019) · Cancers · doi:10.3390/cancers11081156 · Cited by 58
Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection
Ilmer, M., Schiergens, T. S., Renz, B. W., Schneider, C. P., Sargut, M., Waligora, R., Weniger, M., Hartwig, W., Ceyhan, G. O., Frieß, H., et al. (2019) · Surgical Oncology · doi:10.1016/j.suronc.2019.08.010 · Cited by 57
Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer
Huang, H., & Li, H. (2020) · 癌症：英文版 · doi:10.1002/cac2.12129 · Cited by 58
Turtoï, A., Blomme, A., Debois, D., Somja, J., Delvaux, D., Patsos, G., Valentin, E. D., Peulen, O., Mutijima, E. N., Pauw, E. D., et al. (2013) · Hepatology · doi:10.1002/hep.26608 · Cited by 57
On the epigenetic origin of cancer stem cells
Vincent, A., & SEUNINGEN, I. V. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.03.009 · Cited by 56
Barry, S., Chelala, C., Lines, K. E., Sunamura, M., Wang, A., Marelli‐Berg, F. M., Brennan, C. H., Lemoine, N. R., & Crnogorac‐Jurcevic, T. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9532-y · Cited by 55
It's About Time: Lessons for Solid Tumors from Chronic Myelogenous Leukemia Therapy
Westin, J. R., & Kurzrock, R. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0473 · Cited by 56
Epigenetic determinants of metastasis
Patel, S. A., & Vanharanta, S. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.09.008 · Cited by 58
Casals, E., Gustà, M. F., Cobaleda‐Siles, M., García, A., & Puntes, V. (2017) · Cancer Nanotechnology · doi:10.1186/s12645-017-0030-4 · Cited by 56
Evolution of Barrett’s esophagus through space and time at single-crypt and whole-biopsy levels
Martinez, P., Mallo, D., Paulson, T. G., Li, X., Sanchez, C. A., Reid, B. J., Graham, T. A., Kuhner, M. K., & Maley, C. C. (2018) · Nature Communications · doi:10.1038/s41467-017-02621-x · Cited by 55
Next-Generation Sequencing in Clinical Oncology: Next Steps Towards Clinical Validation
Bennett, N. J., & Farah, C. S. (2014) · Cancers · doi:10.3390/cancers6042296 · Cited by 55
Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers
Guo, T., Li, L., Zhong, Q., Rupp, N. J., Charmpi, K., Wong, C. E., Wagner, U., Rueschoff, J. H., Jochum, W., Fankhauser, C. D., et al. (2018) · Life Science Alliance · doi:10.26508/lsa.201800042 · Cited by 52
Looking backward in time to define the chronology of metastasis
Hu, Z., & Curtis, C. N. (2020) · Nature Communications · doi:10.1038/s41467-020-16995-y · Cited by 55
Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells
Yeo, D., Bastian, A., Strauss, H., Saxena, P., Grimison, P., & Rasko, J. E. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031671 · Cited by 59
Re-Evaluating Clonal Dominance in Cancer Evolution
Burrell, R. A., & Swanton, C. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.04.002 · Cited by 54
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas
Amato, E., Mafficini, A., Hirabayashi, K., Lawlor, R. T., Fassan, M., Vicentini, C., Barbi, S., Delfino, P., Sikora, K. O., Rusev, B. C., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5180 · Cited by 55
Stereotactic Radiotherapy for Oligometastasis
Otake, S., & Goto, T. (2019) · Cancers · doi:10.3390/cancers11020133 · Cited by 58
LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer
Cave, D. D., Buonaiuto, S., Sáinz, B., Fantuz, M., Mangini, M., Carrer, A., Domenico, A. D., Iavazzo, T. T., Andolfi, G., Cortina, C., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02516-w · Cited by 56
Burdyga, A., Conant, A. R., Haynes, L. P., Zhang, J., Jalink, K., Sutton, R., Neoptolemos, J. P., Costello, E., & Tepikin, A. V. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.011 · Cited by 54
Targeting Tumor Hypoxia With Hypoxia-Activated Prodrugs
Yeh, J. J., & Kim, W. Y. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.0759 · Cited by 57
Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A
Hoskins, J. W., Jia, J., Flández, M., Parikh, H. M., Xiao, W., Collins, I. J., Emmanuel, M. A., Ibrahim, A. M., Powell, J. I., Zhang, L., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu193 · Cited by 54
How fibrosis influences imaging and surgical decisions in pancreatic cancer
Erkan, M., Hausmann, S., Michalski, C. W., Schlitter, A. M., Fingerle, A. A., Dobritz, M., Frieß, H., & Kleeff, J. H. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00389 · Cited by 54
Valero, V., Saunders, T., He, J. P., Weiss, M. J., Cameron, J. L., Dholakia, A. S., Wild, A. T., Shin, E. J., Khashab, M. A., Lennon, A. M., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001156 · Cited by 55
Self-citationPancreatic cancer: A critical review of dietary risk
Salem, A. A., & Mackenzie, G. G. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.12.001 · Cited by 55
Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma
Sharma, G. G., Okada, Y., Hoff, D. D. V., & Goel, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.10.001 · Cited by 54
Pre-clinical Models of Metastasis in Pancreatic Cancer
Miquel, M., Zhang, S., & Pilarsky, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748631 · Cited by 53
Oncogenes in melanoma: An update
Kunz, M. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.12.002 · Cited by 55
A Meta Analysis of Pancreatic Microarray Datasets Yields New Targets as Cancer Genes and Biomarkers
Goonesekere, N. C. W., Wang, X., Ludwig, L., & Guda, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093046 · Cited by 54
Permuth‐Wey, J., Chen, Y. A., Fisher, K. J., McCarthy, S. M., Qu, X., Lloyd, M. C., Kasprzak, A., Fournier, M., Williams, V. L., Ghia, K. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116869 · Cited by 53
Early onset pancreatic cancer: a controlled trial.
Tingstedt, B., Weitkämper, C., & Andersson, R. E. (2011) · Europe PMC (PubMed Central) · Cited by 53
Han, B., Qu, C., Park, K., Konieczny, S. F., & Korc, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.12.003 · Cited by 53
Greene, S. B., Dago, A. E., Leitz, L., Wang, Y., Lee, J. S. H., Werner, S. L., Gendreau, S. B., Patel, P. H., Jia, S., Zhang, L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165089 · Cited by 56
A population genetics perspective on the determinants of intra-tumor heterogeneity
Hu, Z., Sun, R., & Curtis, C. N. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.03.001 · Cited by 54
3D modeling of cancer stem cell niche
He, J., Xiong, L., Li, Q., Lin, L., Miao, X., Yan, S., Hong, Z., Yang, L., Wen, Y., & Deng, X. (2017) · Oncotarget · doi:10.18632/oncotarget.19847 · Cited by 59
New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis
Felsenstein, M., Hruban, R. H., & Wood, L. D. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000172 · Cited by 59
Self-citationA genetic roadmap of pancreatic cancer: still evolving
Notta, F., Hahn, S. A., & Real, F. X. (2017) · Gut · doi:10.1136/gutjnl-2016-313317 · Cited by 54
Statin use is associated to a reduced risk of pancreatic cancer: A meta-analysis
Archibugi, L., Arcidiacono, P. G., & Capurso, G. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.09.007 · Cited by 53
Early Detection of Pancreatic Cancer
Kenner, B. J. (2018) · Pancreas · doi:10.1097/mpa.0000000000001024 · Cited by 53
Arnedos, M., Vielh, P. R., Soria, J., & André, F. (2013) · The Journal of Pathology · doi:10.1002/path.4276 · Cited by 51
Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma
Nakaoka, K., Ohno, E., Kawabe, N., Kuzuya, T., Funasaka, K., Nakagawa, Y., Nagasaka, M., Ishikawa, T., Watanabe, A., Tochio, T., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13020215 · Cited by 53
Smith, A. L., Alirezaie, N., Connor, A. A., Chan‐Seng‐Yue, M., Grant, R. C., Selander, I., Bascuñana, C., Borgida, A., Hall, A., Whelan, T., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.030 · Cited by 54
Brodovicz, K. G., Kou, T. D., Alexander, C. M., O’Neill, E. A., Engel, S. S., Girman, C. J., & Goldstein, B. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01667.x · Cited by 52
Cao, W., Wu, W., Yan, M., Tian, F., Ma, C., Zhang, Q., Li, X., Han, P., Liu, Z., Gu, J., et al. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.34 · Cited by 52
Şahin, İ. H., Lowery, M. A., Stadler, Z. K., Salo‐Mullen, E. E., Iacobuzio–Donahue, C. A., Kelsen, D. P., & O'Reilly, E. M. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1153424 · Cited by 56
Self-citationBig Bang Tumor Growth and Clonal EvolutionPreprint
Sun, R., Hu, Z., & Curtis, C. N. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028381 · Cited by 61
Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer
Lei, F., Xi, X., Batra, S. K., & Bronich, T. K. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.255786 · Cited by 51
NCI's provocative questions on cancer: some answers to ignite discussion
Blagosklonny, M. V. (2011) · Oncotarget · doi:10.18632/oncotarget.432 · Cited by 51
Heterotopic Pancreas of the Gastrointestinal Tract and Associated Precursor and Cancerous Lesions
Jun, S., Son, D., Kim, M., Kim, S. J., An, S., Park, Y. S., Park, S. R., Choi, K. D., Jung, H., Kim, S. C., et al. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000850 · Cited by 51
Hormonal factors and pancreatic cancer risk in women: The M almö D iet and C ancer S tudy
Andersson, G., Borgquist, S., & Jirström, K. (2018) · International Journal of Cancer · doi:10.1002/ijc.31302 · Cited by 52
Effective screening for early diagnosis of pancreatic cancer
Hanada, K., Okazaki, A., Hirano, N., Izumi, Y., Minami, T., Ikemoto, J., Kanemitsu, K., & Hino, F. (2015) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2015.09.017 · Cited by 51
Naidoo, K., Jones, R. C., Dmitrović, B., Wijesuriya, N., Kocher, H. M., Hart, I. R., & Crnogorac‐Jurcevic, T. (2011) · The Journal of Pathology · doi:10.1002/path.3959 · Cited by 51
Inferring mutational timing and reconstructing tumour evolutionary histories
Turajlic, S., McGranahan, N., & Swanton, C. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.03.005 · Cited by 53
Metabolomics Approaches and Applications in Prostate Cancer Research
Zhang, A., Yan, G., Han, Y., & Wang, X. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-0955-6 · Cited by 51
Zimonjic, D. B., & Popescu, N. C. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1474 · Cited by 53
Hölzel, D., Eckel, R., Bauerfeind, I., Baier, B., Beck, T., Braun, M., Ettl, J., Hamann, U., Kiechle, M. B., Mahner, S., et al. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2428-0 · Cited by 52
Dzobo, K., Senthebane, D. A., Thomford, N. E., Rowe, A., Dandara, C., & Parker, M. I. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0174 · Cited by 54
Paiella, S., Capurso, G., Cavestro, G. M., Butturini, G., Pezzilli, R., Salvia, R., Signoretti, M., Crippa, S., Carrara, S., Frigerio, I. M., et al. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0414-z · Cited by 51
Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer
Kim, T., Jung, S., Baek, I.-W., Lee, S., Choi, Y., Lee, J., Yeun‐Jun, C., & Lee, S. (2014) · The Journal of Pathology · doi:10.1002/path.4380 · Cited by 51
The evolution of failure: explaining cancer as an evolutionary process
Lean, C. H., & Plutynski, A. (2015) · Biology & Philosophy · doi:10.1007/s10539-015-9511-1 · Cited by 56
Stereotactic Body Radiotherapy for Oligometastasis
Correa, R. J. M., Salama, J. K., Milano, M. T., & Palma, D. A. (2016) · The Cancer Journal · doi:10.1097/ppo.0000000000000202 · Cited by 50
Liu, Y., Xu, X., Tang, H., Pan, Y., Hu, B., & Huang, G. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4900 · Cited by 50
Yang, J. A., Zhang, Y., Gao, X., Yuan, Y., Zhao, J., Zhou, S., Wang, H., Wang, L., Xu, G., Li, X., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.628346 · Cited by 52
Hu, P., Chen, X., Sun, J., Bie, P., & Zhang, L.-D. (2014) · Bioscience Reports · doi:10.1042/bsr20140124 · Cited by 50
RetractedBiospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards
Poste, G. H. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.09.003 · Cited by 51
Strategies for early detection of resectable pancreatic cancer
Okano, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11230 · Cited by 50
Tan, I. B., Malik, S., Ramnarayanan, K., McPherson, J. R., Ho, D. L., Suzuki, Y., Ng, S. B. H., Su, Y., Lim, K. H., Koh, D., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0589-1 · Cited by 50
Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer
Hamada, S., Masamune, A., & Shimosegawa, T. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00331 · Cited by 49
Differential expression of neurogenes among breast cancer subtypes identifies high risk patients
Fernández‐Nogueira, P., Bragado, P., Almendro, V., Ametller, E., Ríos, J., Choudhury, S. A., Mancino, M., & Gascón, P. (2015) · Oncotarget · doi:10.18632/oncotarget.6543 · Cited by 48
Iqbal, W., Alkarim, S., Al-Hejin, A. M., Mukhtar, H., & Saini, K. S. (2016) · Oncotarget · doi:10.18632/oncotarget.10942 · Cited by 50
Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer
Takai, E., & Yachida, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i38.8480 · Cited by 53
Self-citationMDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis
Das, S. K., Maji, S., Wechman, S. L., Bhoopathi, P., Pradhan, A. K., Talukdar, S., Sarkar, D., Landry, J. W., Guo, C., Wang, X., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104695 · Cited by 48
Orlando, P. A., Gatenby, R. A., & Brown, J. S. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00045 · Cited by 49
Dumonceau, J., Delhaye, M., Charette, N., & Farina, A. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820927292 · Cited by 52
Li, C.-L. F., Yang, D., Zhao, Y., Qiu, Y., Cao, X., Yu, Y., Guo, H., Gu, X., & Yin, X. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1073763 · Cited by 49
Inflammation and pancreatic cancer: disease promoter and new therapeutic target
Hamada, S., Masamune, A., & Shimosegawa, T. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0915-x · Cited by 50
Sato, K. A., Hachiya, T., Iwaya, T., Kume, K., Matsuo, T., Kawasaki, K., Abiko, Y., Akasaka, R., Matsumoto, T., Otsuka, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146275 · Cited by 51
E-scape: interactive visualization of single-cell phylogenetics and cancer evolution
Smith, M. A., Nielsen, C. B., Chan, F. C., McPherson, A., Roth, A. J. L., Farahani, H., Machev, D., Steif, A., & Shah, S. P. (2017) · Nature Methods · doi:10.1038/nmeth.4303 · Cited by 44
Khalaf, N. I., Yuan, C., Hamada, T., Cao, Y., Babić, A., Morales‐Oyarvide, V., Kraft, P. L., Ng, K., Giovannucci, E. L., Ogino, S., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.12.001 · Cited by 50
Liu, Q., Zhang, R., Michalski, C. W., Liu, B., Liao, Q., & Kleeff, J. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-61487-0 · Cited by 49
Lim, B., Mun, J., Kim, J., Kim, C. W., Roh, S. A., Cho, D., Kim, S., Kim, S., & Kim, J. C. (2015) · Oncotarget · doi:10.18632/oncotarget.4246 · Cited by 48
Cancer sequencing unravels clonal evolution
Caldas, C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2213 · Cited by 48
Ellsworth, K. A., Eckloff, B. W., Li, L., Moon, I., Fridley, B. L., Jenkins, G. D., Carlson, E., Brisbin, A. G., Abo, R., Bamlet, W. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070216 · Cited by 48
Inferring the Origin of Metastases from Cancer Phylogenies
Hong, W. S., Shpak, M., & Townsend, J. P. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1889 · Cited by 48
Sinn, M., Striefler, J. K., Sinn, B. V., Sallmon, D., Bischoff, S., Stieler, J., Pelzer, U., Bahra, M., Neuhaus, P., Dörken, B., et al. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23409 · Cited by 48
The degree of intratumor mutational heterogeneity varies by primary tumor sub-site
Ledgerwood, L. G., Kumar, D., Eterovic, A. K., Wick, J., Chen, K., Zhao, H., Tazi, L., Manna, P., Kerley, S. W., Joshi, R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8448 · Cited by 48
Zhong, Y., Macgregor‐Das, A. M., Saunders, T., Whittle, M. C., Makohon-Moore, A. P., Kohutek, Z. A., Poling, J., Herbst, B. T., Javier, B. M., Cope, L., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1615 · Cited by 46
Self-citationPittman, M. E., Rao, R. A., & Hruban, R. H. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0426-ra · Cited by 49
Self-citationHata, T., Suenaga, M., Marchionni, L., Macgregor-Das, A. M., Yu, J., Shindo, K., Tamura, K., Hruban, R. H., & Goggins, M. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.03.012 · Cited by 49
Self-citationHuang, B., Trujillo, M. A. M., Fujikura, K., Qiu, M., Chen, F., Felsenstein, M., Zhou, C., Skaro, M. F., Gauthier, C. D., Macgregor‐Das, A. M., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5515 · Cited by 48
Self-citationOligometastasis: Past, Present, Future
Gutiontov, S. I., Pitroda, S. P., & Weichselbaum, R. R. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.02.019 · Cited by 50
Identification and Analysis of Precursors to Invasive Pancreatic Cancer
Matthaei, H., Molin, M. D., & Maitra, A. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-287-2_1 · Cited by 47
GLP-1–Based Therapies: The Dilemma of Uncertainty
Spranger, J., Gundert‐Remy, U., & Stammschulte, T. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.019 · Cited by 48
Diagnostic Evaluation and Staging of Pancreatic Ductal Adenocarcinoma
McIntyre, C. A., & Winter, J. M. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.003 · Cited by 47
Li, M., Liu, Y., Zhang, Y., Yu, N., & Li, J. (2023) · Advanced Science · doi:10.1002/advs.202305150 · Cited by 47
The war on cancer: are we winning?
Duffy, M. J. (2013) · Tumor Biology · doi:10.1007/s13277-013-0759-2 · Cited by 47
Bartsch, D. K., Dietzel, K., Bargello, M., Matthaei, E., Kloeppel, G., Esposito, I., Heverhagen, J. T., Gress, T. M., Slater, E. P., & Langer, P. (2012) · Familial Cancer · doi:10.1007/s10689-012-9582-y · Cited by 47
New insights for early intervention and detection
Costello, E., & Neoptolemos, J. P. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.214 · Cited by 47
Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers
Fukushige, S., & Horii, A. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.022 · Cited by 47
Metadata
- Authors
- Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., & Iacobuzio-Donahue, C. A.
- Affiliations
- Johns Hopkins University (US)
- Howard Hughes Medical Institute (US)
- Harvard University (US)
- ORCID
- Venue
- Nature
- Published
- 2010-10
- Volume
- 467
- Issue
- 7319
- Pages
- 1114-1117
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3148940
- OpenAlex
- W2169895148
- Cited by
- 2,502
- References
- 24
- Citations by year
- 2026: 73 · 2025: 84 · 2024: 76 · 2023: 105 · 2022: 122 · 2021: 165 · 2020: 157 · 2019: 147 · 2018: 176 · 2017: 218 · 2016: 208 · 2015: 237 · 2014: 224 · 2013: 182 · 2012: 197
- FWCI
- 50.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (5r01ca121113-15)
- U.S. Public Health Service (A62924)
- National Cancer Institute (R01CA140599, CA 57345, R01-CA121113, CA-121113, CA43460, K08CA106610, R37CA043460, R01CA057345, CA106610, P50CA062924, R37CA057345)
- National Institute of General Medical Sciences (R01GM078986, GM078986)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- pancreatic cancer, distant metastasis, clonal evolution, tumor subclones, chromosomal rearrangements, genomic instability, early detection, tumor heterogeneity, therapeutic target
- MeSH terms
- Adenocarcinoma, Autopsy, Clone Cells, DNA Mutational Analysis, Humans, Liver Neoplasms, Lung Neoplasms, Models, Biological, Mutation, Neoplasm Metastasis, Pancreas, Pancreatic Neoplasms, Peritoneal Neoplasms, Time Factors, Disease Progression, Cell Lineage, Evolution, Molecular, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
